Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Atreca, Inc.
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
December 26, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
IMNM
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives
November 14, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
September 21, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
August 10, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
June 05, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
May 10, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
April 26, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 13, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
March 29, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
March 23, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
March 01, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
February 06, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
January 09, 2023
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
November 10, 2022
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca to Present at Upcoming Investor Conferences
November 07, 2022
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 05, 2022
From
Atreca, Inc.
Via
GlobeNewswire
Tickers
BCEL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.